Crucially, unlike FPS-ZM1's singular RAGE antagonism, BSTJF simultaneously inhibited NOX4-driven ROS overproduction and NF-κB-mediated cytokine release, synergistically disrupting oxidative-inflammatory crosstalk in PCOS. Here, NFKB1 is linked to polycystic ovary syndrome.